Market Overview

Covidien Launches New Shiley Neonatal and Pediatric Tracheostomy Tubes

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today added a new product to its family of ShileyTM neonatal and pediatric tracheostomy tubes. The new cuffless product will help enhance patient care and safety within the hospital and home care environments.

“This new product portfolio represents an important step forward in the care of young patients dependent on tracheostomy tubes,” said Robert J. White, President, Respiratory and Monitoring Solutions, Covidien. “For more than 40 years, clinicians and patients have trusted the Shiley brand for their tracheostomy needs. We are pleased to offer an expanded range of industry-leading solutions for meeting their needs across hospital and home care environments.”

Shiley portfolio innovations for the cuffless design include:

An expanded range of tube sizes down to a 2.5mm inner diameter to accommodate the smallest patients – an option that hasn't previously existed in the Shiley portfolio. A soft, clear flange that facilitates easier examination of the underlying skin for infection and eases trach-tube holder insertion. Tubes manufactured with a medical grade PVC, with a citric-based, non-phthalate plasticizer and meet the latest patient safety standards. The Shiley neonatal and pediatric tracheostomy tubes were recently approved for sale in the United States, Canada and Europe. More information on the product portfolio is available by visiting Covidien.com/RMS. Covidien also offers tracheostomy support resources for patients and physicians through its recently enhanced website LivingwithaVent.com.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries.

Please visit Covidien.com to learn more about our business.

Posted-In: News FDA

 

Most Popular

Related Articles (COV)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free